J1939 HCPCS code: Injection, bumetanide, 0.5 mg
J1939 is the HCPCS Level II code for injection, bumetanide, 0.5 mg. In 2024 Medicare paid an average of $0.49 per service for J1939 across 5,985 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 24 per day on outpatient hospital claims. In 2024, about 277 clinicians billed Medicare for J1939 for 796 beneficiaries; Illinois, Maryland, Pennsylvania accounted for 48% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2024-01-01 |
| Last action effective | 2025-01-01 |
Who bills J1939 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 277 |
| Medicare beneficiaries | 796 |
| States with claims | 17 |
| Share of services in top 3 states (Illinois, Maryland, Pennsylvania) | 48% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1939, 2024–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2024 | 5,985 | 796 | $0.62 | $0.49 |
States with the most J1939 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Illinois | 1,053 | $0.49 |
| Maryland | 877 | $0.49 |
| Pennsylvania | 727 | $0.49 |
| Minnesota | 569 | $0.51 |
| New York | 540 | $0.49 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 24 | Prescribing Information |
| practitioner claims | 24 | Prescribing Information |
What changed for J1939
- 2024-01-01: J1939 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1939?
J1939 is the HCPCS Level II code for injection, bumetanide, 0.5 mg. Short descriptor: "Inj, bumetanide, 0.5 mg".
How much does Medicare pay for J1939?
In 2024, the average Medicare payment was $0.49 per service (average allowed $0.62).
Does Medicare cover J1939?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J1939 can be billed per day?
24 on outpatient hospital claims; 24 on practitioner claims (NCCI medically unlikely edits).
Related J19 codes
- J1920 — Injection, labetalol hydrochloride, 5 mg
- J1921 — Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
- J1930 — Injection, lanreotide, 1 mg
- J1931 — Injection, laronidase, 0.1 mg
- J1932 — Injection, lanreotide, (cipla), 1 mg
- J1938 — Injection, furosemide, 1 mg
- J1940 — Injection, furosemide, up to 20 mg
- J1941 — Injection, furosemide (furoscix), 20 mg
- J1942 — Injection, aripiprazole lauroxil, 1 mg
- J1943 — Injection, aripiprazole lauroxil, (aristada initio), 1 mg
- J1944 — Injection, aripiprazole lauroxil, (aristada), 1 mg
- J1945 — Injection, lepirudin, 50 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1939
- Watch J1939 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1939
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.